Paolo Martelletti (P Martelletti)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 111

Top Venues

International journal of environmental research and public health

Expert review of neurotherapeutics

The journal of headache and pain

Expert opinion on pharmacotherapy

Universita degli Studi di Roma La Sapienza Facolta di Medicina e Psicologia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita degli Studi di Roma La Sapienza Facolta di Medicina e Psicologia

Italy

Associate Professor :: Department of Clinical and Molecular Medicine

Publications

Claudio Tana, David Garcia Azorin, Francesco Cinetto, Cesare Mantini, Marco Tana, Massimo Caulo, Fabrizio Ricci, Paolo Martelletti, Francesco Cipollone, Maria Adele Giamberardino
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis. International journal of molecular sciences 24 (9) (2023)
Elena Gross, Elena Ruiz de la Torre, Paolo Martelletti
The Migraine Stigma Kaleidoscope View. Neurology and therapy (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Claudio Tana, David Garcia Azorin, Francesco Cinetto, Cesare Mantini, Marco Tana, Massimo Caulo, Fabrizio Ricci, Paolo Martelletti, Francesco Cipollone, Maria Adele Giamberardino
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis. International journal of molecular sciences 24 (9) (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
William David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, Dilara Onan, Paolo Martelletti
Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert opinion on investigational drugs (2023)
Dilara Onan, Ozlem Ulger, Paolo Martelletti
Effects of Spinal Stabilization Exercises Delivered Using Telerehabilitation on Outcomes in Patients with Chronic Neck Pain: A Randomized Controlled Trial. Expert review of neurotherapeutics (2023)
William David Wells-Gatnik, Paolo Martelletti
Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal. Expert opinion on drug safety (2023)
Tsubasa Takizawa, Keiko Ihara, Shunsuke Uno, Seiya Ohtani, Narumi Watanabe, Noboru Imai, Jin Nakahara, Satoko Hori, David Garcia-Azorin, Paolo Martelletti
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review. Expert opinion on drug metabolism & toxicology (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Claudio Tana, Francesco Cipollone, Maria Adele Giamberardino, Paolo Martelletti
New drugs targeting calcitonin gene-related peptide for the management of migraines. Expert opinion on emerging drugs (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
Dilara Onan, Samaira Younis, William David Wellsgatnik, Fatemeh Farham, Saulius Andruškevičius, Ana Abashidze, Asel Jusupova, Yuriy Romanenko, Oxana Grosu, Meerimgul Zamirbekovna Moldokulova, Ulkar Mursalova, Saida Saidkhodjaeva, Paolo Martelletti, Sait Ashina
Debate: differences and similarities between tension-type headache and migraine. The journal of headache and pain 24 (1) (2023)
Christina Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome. Journal of comparative effectiveness research (2023)
Alessia Marcassoli, Matilde Leonardi, Marco Passavanti, Valerio De Angelis, Enrico Bentivegna, Paolo Martelletti, Alberto Raggi
Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic. International journal of environmental research and public health 20 (3) (2023)
Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, Christian Lampl, Paolo Martelletti
New Migraine Drugs for Older Adults. Drugs & aging (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Paolo Martelletti
COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache. International journal of environmental research and public health 20 (5) (2023)
William David Wells-Gatnik, Paolo Martelletti
Gepants in the acute management of migraine. Pain management (2023)
Paolo Martelletti
One Health for Headaches: A Clinical Scientist Residence Project. International journal of environmental research and public health 20 (6) (2023)
Dilara Onan, Ozlem Ulger, Paolo Martelletti
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial. Expert review of neurotherapeutics (2023)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Andrew Blumenfeld, Aud Nome Dueland, Stefan Evers, Bronwyn Jenkins, Paolo Martelletti, Katherine Sommer
Practical Insights on the Identification and Management of Patients with Chronic Migraine. Pain and therapy 11 (2) (2022)
Enrico Bentivegna, Silvia Di Meo, Anita Carriero, Nadia Capriotti, Alberto Barbieri, Paolo Martelletti
Access to COVID-19 Vaccination during the Pandemic in the Informal Settlements of Rome. International journal of environmental research and public health 19 (2) (2022)
Dilara Onan, William David Wells-Gatnik, Paolo Martelletti
Reaching the Nadir of Medication Overuse in Chronic Migraine. International journal of environmental research and public health 19 (22) (2022)
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil-Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M Boucherie, Patricia Pozo-Rosich, Margarita Sanchez Del Rio, Alexandra Jean Sinclair, Antoinette MaassenVanDenBrink, Uwe Reuter
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. The journal of headache and pain 23 (1) (2022)
Claudia Altamura, Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, A M Miscio, A Santoro, Alicia Alpuente, A Russo, M Silvestro, Sabina Cevoli, Nicoletta Brunelli, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, I Frattale, K Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, E Filatova, Nina V Latysheva, A Gryglas-Dworak, Marcin Straburzyński, C Butera, B Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco, Fabrizio Vernieri
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study. Journal of neurology (2022)
Enrico Bentivegna, Cristina Tassorelli, Roberto De Icco, Grazia Sances, Paolo Martelletti
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes. Expert review of neurotherapeutics 22 (3) (2022)
Fidel Dominique Festin Ambat, Enrico Bentivegna, Paolo Martelletti
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (3) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Martina Cacciatore, Alberto Raggi, Andrea Pilotto, Viviana Cristillo, Erika Guastafierro, Claudia Toppo, Francesca Giulia Magnani, Davide Sattin, Arianna Mariniello, Fabiola Silvaggi, Stefano Cotti Piccinelli, Nicola Zoppi, Giulio Bonzi, Stefano Gipponi, Ilenia Libri, Michela Bezzi, Paolo Martelletti, Matilde Leonardi, Alessandro Padovani
Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis. International journal of environmental research and public health 19 (7) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Alberto Raggi, Matilde Leonardi, Simona Sacco, Paolo Martelletti
Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity. Pain and therapy 11 (2) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
Farzaneh Allahdinian Hesaruiyeh, Saeed Rajabi, Mohadeseh Motamed-Jahromi, Mohammad Sarhadi, Michelle L Bell, Razieh Khaksefidi, Somayeh Sarhadi, Leili Mohammadi, Kamal Dua, Amin Mohammadpour, Paolo Martelletti
A Pilot Study on the Association of Lead, 8-Hydroxyguanine, and Malondialdehyde Levels in Opium Addicts' Blood Serum with Illicit Drug Use and Non-Addict Persons. International journal of environmental research and public health 19 (15) (2022)
Paolo Martelletti, Enrico Bentivegna
Insights into headache 2022. Expert review of neurotherapeutics 22 (2) (2022)
Dilara Onan, Paolo Martelletti
Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? International journal of environmental research and public health 19 (23) (2022)
Enrico Bentivegna, Michelangelo Luciani, Valeria Ferrari, Silvia Galastri, Francesco Baldari, Francesco Scarso, Piera A Lamberti, Paolo Martelletti
Recently approved and emerging drug options for migraine prophylaxis. Expert opinion on pharmacotherapy 23 (11) (2022)
Dilara Onan, Enrico Bentivegna, Paolo Martelletti
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity. Toxins 15 (1) (2022)
William David Wells-Gatnik, Fidel Dominique Festin Ambat, Paolo Martelletti
Hesitancies in primary headaches treatments. Expert review of neurotherapeutics 22 (9) (2022)
Silvia Benemei, Enrico Bentivegna, Paolo Martelletti
Positioning the new drugs for migraine. Expert opinion on drug metabolism & toxicology 18 (1) (2022)
Paolo Martelletti, Martina Curto
Unmet needs for migraine. Current medical research and opinion 37 (11) (2021)
Michelangelo Luciani, Andrea Negro, Valerio Spuntarelli, Enrico Bentivegna, Paolo Martelletti
Evaluating and managing severe headache in the emergency department. Expert review of neurotherapeutics 21 (3) (2021)
Paolo Martelletti, Michelangelo Luciani, Valerio Spuntarelli, Enrico Bentivegna
Deprescribing in migraine. Expert opinion on drug safety 20 (6) (2021)
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Alicia Alpuente, Antonio Russo, Marcello Silvestro, Sabina Cevoli, Nicoletta Brunelli, Fabrizio Vernieri, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, Katharina Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, Elena Filatova, Nina V Latysheva, Anna Gryglas-Dworak, Marcin Straburzyński, Calogera Butera, Bruno Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients. Pain and therapy 10 (2) (2021)
Marcin Straburzyński, Anna Gryglas-Dworak, Magdalena Nowaczewska, Eliza Brożek-Mądry, Paolo Martelletti
Etiology of 'Sinus Headache'-Moving the Focus from Rhinology to Neurology. A Systematic Review. Brain sciences 11 (1) (2021)
Enrico Bentivegna, Michelangelo Luciani, Francesco Scarso, Clara Bruscia, Dario Chiappino, Emanuele Amore, Gabriele Nalli, Paolo Martelletti
Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert review of neurotherapeutics (2021)
Paolo Martelletti, Todd J Schwedt, Pamela Vo, Daniela Ritrovato, Margaret C Reilly, Mariantonietta Naclerio, Pallavi Ranjan, Joern Kleebach, Parth Joshi
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey. Journal of medical economics 24 (1) (2021)
Licia Grazzi, Claudia Toppo, Domenico D'Amico, Matilde Leonardi, Paolo Martelletti, Alberto Raggi, Erika Guastafierro
Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches. International journal of environmental research and public health 18 (4) (2021)
Enrico Bentivegna, Michelangelo Luciani, Vincenzo Paragliola, Francesco Baldari, Piera A Lamberti, Giulia Conforti, Valerio Spuntarelli, Paolo Martelletti
Recent advancements in tension-type headache: a narrative review. Expert review of neurotherapeutics 21 (7) (2021)
Enrico Bentivegna, Michelangelo Luciani, Luca Arcari, Iolanda Santino, Maurizio Simmaco, Paolo Martelletti
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study. International journal of environmental research and public health 18 (3) (2021)
Paolo Martelletti, Martina Curto
Cluster Headache is Still Lurking in the Shadows. Pain and therapy 10 (2) (2021)
Paolo Martelletti, E Bentivegna, V Spuntarelli, M Luciani
Long-COVID Headache. SN comprehensive clinical medicine (2021)
Valerio Spuntarelli, Andrea Negro, Michelangelo Luciani, Enrico Bentivegna, Paolo Martelletti
Eptinezumab for the treatment of migraine. Expert opinion on biological therapy 21 (8) (2021)
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Alicia Alpuente, Antonio Russo, Marcello Silvestro, Sabina Cevoli, Nicoletta Brunelli, Fabrizio Vernieri, Licia Grazzi, Baraldi Carlo, Simona Guerzoni, Anna P Andreou, Giorgio Lambru, Ilaria Frattale, Katharina Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, Elena Filatova, Nina V Latysheva, Anna Gryglas-Dworak, Marcin Straburzynski, Calogera Butera, Bruno Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study. Pain and therapy 10 (1) (2021)
Anna K Eigenbrodt, Håkan Ashina, Sabrina Khan, Hans-Christoph Diener, Dimos D Mitsikostas, Alexandra Jean Sinclair, Patricia Pozo-Rosich, Paolo Martelletti, Anne Ducros, Michel Lantéri-Minet, Mark Braschinsky, Margarita Sanchez Del Rio, Oved Daniel, Aynur Özge, Ayten Mammadbayli, Mihails Arons, Kirill Skorobogatykh, Vladimir Romanenko, Gisela M Terwindt, Koen Paemeleire, Simona Sacco, Uwe Reuter, Christian Lampl, Henrik Winther Schytz, Zaza Katsarava, Timothy J Steiner, Messoud Ashina
Diagnosis and management of migraine in ten steps. Nature reviews. Neurology 17 (8) (2021)
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, Ottavia De Luca, Fabiola Cipolla, Luana Lionetto, Maurizio Simmaco, Paolo Martelletti
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. Journal of clinical medicine 10 (7) (2021)
Matilde Leonardi, Licia Grazzi, Domenico D'Amico, Paolo Martelletti, Erika Guastafierro, Claudia Toppo, Alberto Raggi
Global Burden of Headache Disorders in Children and Adolescents 2007-2017. International journal of environmental research and public health 18 (1) (2020)
Andrea Negro, Valerio Spuntarelli, Paolo Sciattella, Paolo Martelletti
Rapid referral for headache management from emergency department to headache centre: four years data. The journal of headache and pain 21 (1) (2020)
Andrea Negro, Paolo Martelletti
Novel synthetic treatment options for migraine. Expert opinion on pharmacotherapy 22 (7) (2020)
Paolo Martelletti
"Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies. Pain and therapy 9 (2) (2020)
Paolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, Valerio Spuntarelli
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate. SN comprehensive clinical medicine (2020)
Luigi Martelletti, Paolo Martelletti
Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor. SN comprehensive clinical medicine (2020)
Antonio Del Casale, Stefano Ferracuti, Alessio Mosca, Leda Marina Pomes, Federica Fiaschè, Luca Bonanni, Marina Borro, Giovanna Gentile, Paolo Martelletti, Maurizio Simmaco
Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms. International journal of environmental research and public health 17 (18) (2020)
Domenico D'Amico, Stewart J Tepper, Erika Guastafierro, Claudia Toppo, Matilde Leonardi, Licia Grazzi, Paolo Martelletti, Alberto Raggi
Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability. International journal of environmental research and public health 18 (1) (2020)
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, Martina Guglielmetti, Paolo Martelletti
Acute headache management in emergency department. A narrative review. Internal and emergency medicine 15 (1) (2020)
Michelangelo Luciani, Enrico Bentivegna, Valerio Spuntarelli, Piera Amoriello Lamberti, Giulio Cacioli, Flavia Del Porto, Giorgio Sesti, Paolo Martelletti, Luciano De Biase
Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? Journal of medical virology 93 (4) (2020)
Simona Sacco, Antonio Russo, Pierangelo Geppetti, Licia Grazzi, Andrea Negro, Cristina Tassorelli, Gioacchino Tedeschi, Paolo Martelletti
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group. Expert review of neurotherapeutics 20 (12) (2020)
Martina Curto, Matilde Capi, Fabiola Cipolla, Giusy Ylenia Cisale, Paolo Martelletti, Luana Lionetto
Ubrogepant for the treatment of migraine. Expert opinion on pharmacotherapy 21 (7) (2020)
Alfredo Pennica, Giulia Conforti, Francesca Falangone, Antonio Martocchia, Laura Tafaro, Alberto Sentimentale, Valentina Marini, Aldo Pezzuto, Valerio Spuntarelli, Paolo Martelletti
Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review. SN comprehensive clinical medicine (2020)
Antonio Martocchia, Marta Scarienzi, Pietro Prunas, Enrico Bentivegna, Mauro Cacciafesta, Paolo Martelletti, Giorgio Sesti
The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer's disease. F1000Research 9 (2020)
Eleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, Valerio Spuntarelli, Paolo Martelletti, Simona Sacco
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives. Expert review of neurotherapeutics 20 (6) (2020)
Luana Lionetto, Martina Guglielmetti, Fabiola Cipolla, Simone Bernardini, Bianca Emanuela Koehler, Matilde Capi, Donatella De Bernardini, Martina Curto, Roberto Manetti, Ferdinando Nicoletti, Maurizio Simmaco, Paolo Martelletti
Polyamines serum levels in episodic and chronic migraine. Expert review of neurotherapeutics 21 (2) (2020)
Paolo Martelletti
Combination therapy in migraine: asset or issue? Expert review of neurotherapeutics 20 (10) (2020)
Raffaele Ornello, Marianne Canonico, Gabriele S Merki-Feld, Tobias Kurth, Øjvind Lidegaard, E Anne MacGregor, Christian Lampl, Rossella Elena Nappi, Paolo Martelletti, Simona Sacco
Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research. Expert review of neurotherapeutics 20 (4) (2020)
Martina Guglielmetti, Gianluca Serafini, Mario Amore, Paolo Martelletti
The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible Differences. International journal of environmental research and public health 17 (11) (2020)
Antonio Martocchia, Marta Scarienzi, Pietro Prunas, Enrico Bentivegna, Mauro Cacciafesta, Paolo Martelletti, Giorgio Sesti
The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer's disease. F1000Research 9 (2020)
Marina Borro, Martina Guglielmetti, Maurizio Simmaco, Paolo Martelletti, Giovanna Gentile
The future of pharmacogenetics in the treatment of migraine. Pharmacogenomics 20 (16) (2019)
Leda Marina Pomes, Giovanna Gentile, Maurizio Simmaco, Marina Borro, Paolo Martelletti
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine. CNS drugs 32 (6) (2019)
Andrea Negro, Paolo Martelletti
Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies. Expert review of neurotherapeutics 19 (8) (2019)
Luana Lionetto, Martina Curto, Giusy Ylenia Cisale, Matilde Capi, Fabiola Cipolla, Martina Guglielmetti, Paolo Martelletti
Fremanezumab for the preventive treatment of migraine in adults. Expert review of clinical pharmacology 12 (8) (2019)
Paolo Martelletti, Martina Guglielmetti
Approaching the appropriate pharmacotherapy of menstrual migraine. Expert review of neurotherapeutics 20 (1) (2019)
Martina Guglielmetti, Alberto Raggi, Raffaele Ornello, Simona Sacco, Domenico D'Amico, Matilde Leonardi, Paolo Martelletti
The clinical and public health implications and risks of widening the definition of chronic migraine. Cephalalgia : an international journal of headache 40 (4) (2019)
Paolo Martelletti, Lars Edvinsson, Messoud Ashina
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs). The journal of headache and pain 20 (1) (2019)
Paolo Martelletti, Messoud Ashina, Lars Edvinsson
The changing faces of migraine. The journal of headache and pain 20 (1) (2019)
Isabella Berardelli, Salvatore Sarubbi, Dorian A Lamis, Elena Rogante, Valeria Canzonetta, Andrea Negro, Martina Guglielmetti, Alice Sparagna, Valerio De Angelis, Denise Erbuto, Maurizio Pompili, Paolo Martelletti
Job Satisfaction Mediates the Association between Perceived Disability and Work Productivity in Migraine Headache Patients. International journal of environmental research and public health 16 (18) (2019)
Angela Koverech, Claudia Cicione, Luana Lionetto, Marta Maestri, Francesco Passariello, Elisabetta Sabbatini, Matilde Capi, Cristiano Maria De Marco, Martina Guglielmetti, Andrea Negro, Luisa Di Menna, Maurizio Simmaco, Ferdinando Nicoletti, Paolo Martelletti
Migraine and cluster headache show impaired neurosteroids patterns. The journal of headache and pain 20 (1) (2019)
Leda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, Maurizio Simmaco, Marina Borro, Paolo Martelletti
Optimising migraine treatment: from drug-drug interactions to personalized medicine. The journal of headache and pain 20 (1) (2019)
Andrea Negro, Paolo Sciattella, Daniele Rossi, Martina Guglielmetti, Paolo Martelletti, Francesco Saverio Mennini
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre. The journal of headache and pain 20 (1) (2019)
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti, Luana Lionetto
Profiling lasmiditan as a treatment option for migraine. Expert opinion on pharmacotherapy 21 (2) (2019)
Andrea Negro, Paolo Martelletti
Gepants for the treatment of migraine. Expert opinion on investigational drugs 28 (6) (2019)
Paolo Martelletti, Maria Adele Giamberardino
Advances in orally administered pharmacotherapy for the treatment of migraine. Expert opinion on pharmacotherapy 20 (2) (2018)
Angela Koverech, Valeriano Soldati, Vittoria Polidori, Leda Marina Pomes, Luana Lionetto, Matilde Capi, Andrea Negro, Maurizio Simmaco, Paolo Martelletti
Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach. International journal of environmental research and public health 15 (8) (2018)
Matilde Capi, Giovanna Gentile, Luana Lionetto, Gerardo Salerno, Fabiola Cipolla, Martina Curto, Marina Borro, Paolo Martelletti
Pharmacogenetic considerations for migraine therapies. Expert opinion on drug metabolism & toxicology 14 (11) (2018)

Paolo Martelletti.css-eqlu8i{font-size:small;padding-left:4px;} (P Martelletti)

Publication Activity (10 Years)

Top Topics

Top Venues

Paolo Martelletti (P Martelletti)